Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the announcement by the Prime Minister at the G7 Summit that all UK-funded clinical trials will be made openly available, what steps he is taking to require companies to publish such trials; and which diseases will be covered.

The Prime Minister has written to government departments setting out his expectations on open data and transparency. Work is underway to take forward the transparency agenda nationally and internationally. This will cover diseases that are a threat to health security, for example emerging infectious diseases with pandemic potential.